TMSB4Y
gene geneOn this page
Also known as TB4Y
Summary
TMSB4Y (thymosin beta 4 Y-linked, HGNC:11882) is a protein-coding gene on chromosome Yq11.221, encoding Thymosin beta-4, Y-chromosomal (O14604). Plays an important role in the organization of the cytoskeleton.
This gene lies within the male specific region of chromosome Y. Its homolog on chromosome X escapes X inactivation and encodes an actin sequestering protein.
Source: NCBI Gene 9087 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 6 total
- MANE Select transcript:
NM_004202
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11882 |
| Approved symbol | TMSB4Y |
| Name | thymosin beta 4 Y-linked |
| Location | Yq11.221 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TB4Y |
| Ensembl gene | ENSG00000154620 |
| Ensembl biotype | protein_coding |
| OMIM | 400017 |
| Entrez | 9087 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000284856
RefSeq mRNA: 1 — MANE Select: NM_004202
NM_004202
CCDS: CCDS14786
Canonical transcript exons
ENST00000284856 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001016870 | 13703899 | 13704435 |
| ENSE00001274354 | 13705225 | 13706024 |
Expression profiles
Bgee: expression breadth ubiquitous, 112 present calls, max score 88.38.
FANTOM5 (CAGE): breadth broad, TPM avg 0.4041 / max 21.4550, expressed in 205 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201173 | 0.4041 | 205 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.38 | gold quality |
| corpus callosum | UBERON:0002336 | 80.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.09 | gold quality |
| rectum | UBERON:0001052 | 77.42 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 75.56 | gold quality |
| quadriceps femoris | UBERON:0001377 | 71.42 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 70.56 | gold quality |
| ventricular zone | UBERON:0003053 | 70.18 | gold quality |
| prostate gland | UBERON:0002367 | 66.25 | gold quality |
| metanephros cortex | UBERON:0010533 | 66.01 | gold quality |
| cerebellar vermis | UBERON:0004720 | 65.67 | gold quality |
| ganglionic eminence | UBERON:0004023 | 65.20 | gold quality |
| putamen | UBERON:0001874 | 64.19 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 63.14 | gold quality |
| calcaneal tendon | UBERON:0003701 | 62.56 | gold quality |
| hypothalamus | UBERON:0001898 | 62.54 | gold quality |
| nucleus accumbens | UBERON:0001882 | 61.33 | gold quality |
| prefrontal cortex | UBERON:0000451 | 61.30 | gold quality |
| substantia nigra | UBERON:0002038 | 61.10 | gold quality |
| right lung | UBERON:0002167 | 60.85 | gold quality |
| Ammon’s horn | UBERON:0001954 | 60.77 | gold quality |
| right testis | UBERON:0004534 | 60.71 | gold quality |
| testis | UBERON:0000473 | 60.69 | gold quality |
| caudate nucleus | UBERON:0001873 | 60.65 | gold quality |
| spinal cord | UBERON:0002240 | 60.62 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 60.62 | gold quality |
| cerebral cortex | UBERON:0000956 | 60.39 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 60.25 | gold quality |
| left testis | UBERON:0004533 | 59.93 | gold quality |
| thymus | UBERON:0002370 | 59.67 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-11 | no | 25.92 |
| E-ANND-3 | no | 1.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
60 targeting TMSB4Y, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-520F-3P | 99.82 | 71.32 | 1216 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
Literature-anchored findings (GeneRIF, showing 4)
- TMSB4Y has been found to encode a novel HLA-A*3303-restricted minor histocompatibility H-Y antigen, revealed during cytotoxicity assays of T cell lines from a female-to-male hemopoietic stem cell transplantation patient. (PMID:15557202)
- T beta 4 is a key activator of NK cell cytotoxicity. (PMID:19369144)
- Suggest Y chromosome gene TMSB4Y may function as a tumor suppressor gene in male breast cancer. (PMID:26702755)
- miR-183/TMSB4Y, a new potential signaling axis, involving in the progression of laryngeal cancer via modulating cell adhesion. (PMID:33356743)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmsb4x | ENSMUSG00000049775 |
| rattus_norvegicus | Tmsb4x | ENSRNOG00000047931 |
Paralogs (1): TMSB4X (ENSG00000205542)
Protein
Protein identifiers
Thymosin beta-4, Y-chromosomal — O14604 (reviewed: O14604)
All UniProt accessions (1): O14604
UniProt curated annotations — full annotation on UniProt →
Function. Plays an important role in the organization of the cytoskeleton. Binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization.
Subcellular location. Cytoplasm. Cytoskeleton.
Tissue specificity. Ubiquitous.
Similarity. Belongs to the thymosin beta family.
RefSeq proteins (1): NP_004193* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001152 | Beta-thymosin | Family |
| IPR038386 | Beta-thymosin_sf | Homologous_superfamily |
Pfam: PF01290
UniProt features (4 total): compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14604-F1 | 80.52 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
CAR_TNFRSF25, MODULE_16, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, MODULE_118, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, MUELLER_PLURINET, GOBP_ACTIN_FILAMENT_ORGANIZATION, MODULE_88, GOMF_ACTIN_BINDING, GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION, GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH, GRADE_COLON_AND_RECTAL_CANCER_UP, MODULE_104, MODULE_55, RNCTGNYNRNCTGNY_UNKNOWN
GO Biological Process (3): actin filament organization (GO:0007015), regulation of actin polymerization or depolymerization (GO:0008064), regulation of cell migration (GO:0030334)
GO Molecular Function (4): actin monomer binding (GO:0003785), protein sequestering activity (GO:0140311), actin binding (GO:0003779), protein binding (GO:0005515)
GO Cellular Component (4): nucleus (GO:0005634), cytosol (GO:0005829), cytoskeleton (GO:0005856), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| actin cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| actin polymerization or depolymerization | 1 |
| regulation of actin filament length | 1 |
| regulation of actin filament organization | 1 |
| cell migration | 1 |
| regulation of cell motility | 1 |
| actin binding | 1 |
| protein binding | 1 |
| molecular sequestering activity | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
346 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMSB4Y | USP9Y | O00507 | 903 |
| TMSB4Y | KDM5D | Q9BY66 | 893 |
| TMSB4Y | UTY | O14607 | 879 |
| TMSB4Y | DDX3Y | O15523 | 865 |
| TMSB4Y | ZFY | P08048 | 770 |
| TMSB4Y | EIF1AY | O14602 | 740 |
| TMSB4Y | RPS4Y1 | P22090 | 706 |
| TMSB4Y | PRKY | O43930 | 670 |
| TMSB4Y | VCY | O14598 | 666 |
| TMSB4Y | NLGN4Y | Q8NFZ3 | 611 |
| TMSB4Y | AMELY | Q99218 | 608 |
| TMSB4Y | BPY2 | O14599 | 605 |
| TMSB4Y | TBL1Y | Q9BQ87 | 598 |
| TMSB4Y | RBMY1A1 | P0DJD3 | 574 |
| TMSB4Y | CDY2A | Q9Y6F7 | 572 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMSB4Y | TERF2IP | psi-mi:“MI:0915”(physical association) | 0.510 |
| TERF1 | TMSB4Y | psi-mi:“MI:0915”(physical association) | 0.370 |
| POT1 | TMSB4Y | psi-mi:“MI:0915”(physical association) | 0.370 |
| EWSR1 | TMSB4Y | psi-mi:“MI:0915”(physical association) | 0.370 |
| TMSB4Y | WDR46 | psi-mi:“MI:0914”(association) | 0.350 |
| TERF2IP | TMSB4Y | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (41): TMSB4Y (Two-hybrid), DCAF13 (Affinity Capture-MS), RRP1 (Affinity Capture-MS), LRSAM1 (Affinity Capture-MS), SAFB2 (Affinity Capture-MS), RP9 (Affinity Capture-MS), LRCH3 (Affinity Capture-MS), ZC3H13 (Affinity Capture-MS), WBP11 (Affinity Capture-MS), MYO1E (Affinity Capture-MS), DIDO1 (Affinity Capture-MS), TMSB4Y (Reconstituted Complex), SNRNP27 (Affinity Capture-MS), RBMXL1 (Affinity Capture-MS), BUD13 (Affinity Capture-MS)
ESM2 similar proteins: A0A0G0MF47, A4IMM1, A4IMM3, A7GQV6, A7GQV9, A7Z2M2, A7Z565, A8FDQ8, A8FDQ9, A9VNW3, B7GI77, B7HAY1, B7HC95, B7I057, B7I063, B7IRQ5, B7ISF6, B7JI38, B7JI46, B9IUC1, B9IUC7, C0H3V3, C0H402, C1EN49, C1EN57, C3L9B6, C3L9C4, C3P450, C3P458, C5D5S3, C5D9Z3, G2TRU3, O14604, O31572, O31659, P71032, Q5L0A5, Q5L0A7, Q65J28, Q65J29
Diamond homologs: O14604, P0CG34, P0CG35, P0DX04, P18758, P20065, P21752, P21753, P26351, P26352, P33248, P34032, P62326, P62327, P62328, P62329, P63312, P63313, P63314, Q5R7H8, Q6S9C5, Q6ZWY8, Q7YRC3, Q8T697, Q95274, Q9DET5, Q9DFJ9, Q9I954, Q9I955, Q9I980, Q9W7M8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
308 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| Y:13704432:GAAA:G | donor_gain | 1.0000 |
| Y:13704433:A:T | donor_gain | 1.0000 |
| Y:13704436:G:GG | donor_gain | 1.0000 |
| Y:13705216:T:TA | acceptor_gain | 0.9900 |
| Y:13703931:G:GT | donor_gain | 0.9800 |
| Y:13703931:G:T | donor_gain | 0.9800 |
| Y:13704431:AGAAA:A | donor_gain | 0.9800 |
| Y:13704432:GAAAG:G | donor_gain | 0.9800 |
| Y:13704433:AAAGT:A | donor_loss | 0.9800 |
| Y:13704435:AG:A | donor_loss | 0.9800 |
| Y:13704436:GT:G | donor_loss | 0.9800 |
| Y:13704437:T:A | donor_loss | 0.9800 |
| Y:13704319:C:CA | acceptor_gain | 0.9700 |
| Y:13704434:AA:A | donor_gain | 0.9600 |
| Y:13704320:G:A | acceptor_gain | 0.9500 |
| Y:13704433:AAA:A | donor_gain | 0.9500 |
| Y:13705217:G:A | acceptor_gain | 0.9500 |
| Y:13703996:G:GT | donor_gain | 0.9300 |
| Y:13704318:AC:A | acceptor_gain | 0.9300 |
| Y:13705224:GCT:G | acceptor_gain | 0.9300 |
| Y:13705223:A:AG | acceptor_gain | 0.9200 |
| Y:13705224:G:GG | acceptor_gain | 0.9200 |
| Y:13704319:C:G | acceptor_gain | 0.8900 |
| Y:13705206:T:A | acceptor_gain | 0.8900 |
| Y:13703963:G:GT | donor_gain | 0.8700 |
| Y:13705221:GCAG:G | acceptor_loss | 0.8700 |
| Y:13705222:CA:C | acceptor_loss | 0.8700 |
| Y:13705223:AGC:A | acceptor_loss | 0.8700 |
| Y:13705224:G:GT | acceptor_loss | 0.8700 |
| Y:13704177:G:GT | donor_gain | 0.8600 |
AlphaMissense
289 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| Y:13704372:T:C | F13L | 0.619 |
| Y:13704374:C:A | F13L | 0.619 |
| Y:13704374:C:G | F13L | 0.619 |
dbSNP variants (sampled 300 via entrez): RS1005517418 (Y:13704249 G>A), RS1005842717 (Y:13702167 C>T), RS1006983496 (Y:13703443 C>A,T), RS1018505160 (Y:13702234 C>G), RS1019329879 (Y:13703447 T>A), RS1021120701 (Y:13703513 A>T), RS1029840337 (Y:13702485 T>A), RS1029869279 (Y:13704946 A>G), RS1032682046 (Y:13705201 T>C), RS1039756838 (Y:13706166 G>C), RS1039998769 (Y:13704267 C>A), RS1045600241 (Y:13703805 G>C), RS1047181223 (Y:13705795 A>G), RS1048348593 (Y:13703435 C>T), RS113175306 (Y:13705628 A>T)
Disease associations
OMIM: gene MIM:400017 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| Tretinoin | affects expression, increases expression | 2 |
| arsenite | decreases methylation | 1 |
| tamibarotene | affects expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Silicon Dioxide | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | increases expression, increases abundance | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D6SS | WAe001-A-2F | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.